Aurora Cannabis (TSE:ACB) Cut to “Tender” at ATB Cormark Capital Markets

ATB Cormark Capital Markets downgraded shares of Aurora Cannabis (TSE:ACB) from an outperform rating to a tender rating in a research report report published on Wednesday,BayStreet.CA reports. ATB Cormark Capital Markets currently has C$5.60 target price on the stock, down from their previous target price of C$6.50.

Several other brokerages have also weighed in on ACB. TD dropped their target price on Aurora Cannabis from C$10.00 to C$8.00 and set a “buy” rating on the stock in a research report on Friday, June 12th. BMO Capital Markets raised shares of Aurora Cannabis to a “hold” rating in a report on Wednesday, August 5th. Finally, Canaccord Genuity Group lowered their price target on shares of Aurora Cannabis from C$6.50 to C$5.00 and set a “buy” rating for the company in a research report on Tuesday, June 30th. Two research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of C$6.20.

Aurora Cannabis Stock Up 3.0%

TSE:ACB opened at C$5.41 on Wednesday. The firm has a market capitalization of C$335.19 million, a PE ratio of -2.79 and a beta of 0.25. The stock has a 50 day moving average of C$4.16 and a 200-day moving average of C$4.58. Aurora Cannabis has a 52 week low of C$3.59 and a 52 week high of C$9.33. The company has a current ratio of 5.36, a quick ratio of 2.48 and a debt-to-equity ratio of 4.30.

Aurora Cannabis (TSE:ACB) last announced its quarterly earnings results on Wednesday, August 5th. The company reported C($0.07) earnings per share for the quarter. The company had revenue of C$67.55 million for the quarter. Aurora Cannabis had a negative return on equity of 5.21% and a negative net margin of 9.53%. Analysts predict that Aurora Cannabis will post -0.22 EPS for the current year.

About Aurora Cannabis

Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael ’71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.